Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CK Life Sciences International (Holdings), Inc. ( (HK:0775) ) has issued an announcement.
CK Life Sciences has renewed its intra‑group service relationship by having its wholly owned subsidiary, RMSPL, enter into a new management agreement with IPL, a wholly owned subsidiary of Cheung Kong Asset (CKA), to provide comprehensive management, property, leasing, acquisition/disposal and redevelopment services for IPL’s properties in designated territories from 1 January 2026 to 31 December 2028. As IPL is a connected person under Hong Kong listing rules, the arrangement constitutes a continuing connected transaction; however, because the annual caps fall between 0.1% and 5% of the applicable size tests, the deal is subject only to reporting, announcement and annual review requirements and is exempt from independent shareholders’ approval, ensuring continuity of fee income and operational alignment within the group with limited compliance burden.
The most recent analyst rating on (HK:0775) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on CK Life Sciences International (Holdings), Inc. stock, see the HK:0775 Stock Forecast page.
More about CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings) Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates through subsidiaries in providing management and related services, including property and asset management, within the wider Cheung Kong group ecosystem, focusing on supporting affiliated entities’ real estate and investment activities.
Average Trading Volume: 7,481,977
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.07B
For an in-depth examination of 0775 stock, go to TipRanks’ Overview page.